Clinical Trial Update: Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Suxiao Jiuxin Pill for stabilization of vulnerable plaque in acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Suxiao Jiuxin Pill

Snippet

Sponsor: Xiaolu Li | Conditions: Acute Myocardial Infarction | Phase 4 | Status: NOT_YET_RECRUITING